Clinical Data BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival pharminent May 12, 2026
Clinical Data QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS pharminent May 5, 2026
Clinical Data Celcuity strengthens case for ASCO-spotlighted breast cancer drug pharminent May 4, 2026
Clinical Data Summit shares descend as PD-1/VEGF asset misses early survival mark pharminent May 4, 2026
Clinical Data GSK-partnered Alector hit with third neuro failure as Alzheimer’s asset disappoints pharminent April 30, 2026
Clinical Data Survodutide delivers 16.6% weight loss in major phase 3 obesity trial pharminent April 30, 2026
Clinical Data Boehringer, Zealand’s obesity drug ‘more akin’ to Novo’s Wegovy in Phase 3 pharminent April 28, 2026
Clinical Data AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer pharminent April 28, 2026
Clinical Data Oruka surges as long-acting psoriasis drug shows early promise pharminent April 27, 2026
Clinical Data Cardiometabolic trials: Using expertise to turn complexity into robust results pharminent April 24, 2026
Clinical Data AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data pharminent April 23, 2026
Clinical Data Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial pharminent April 22, 2026
Clinical Data Ionis’ antisense drug stabilizes ultra-rare disease ahead of FDA decision pharminent April 22, 2026
Clinical Data BioAge says early data suggest ‘best-in-class’ potential for inflammation drug pharminent April 21, 2026
Clinical Data Merck, Eisai’s Keytruda triplet fails to improve survival in kidney cancer pharminent April 21, 2026
Clinical Data AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data pharminent April 21, 2026
Clinical Data Gilead, Arcus tumble again in TIGIT, triggering 2 trial culls pharminent April 21, 2026
Clinical Data Nektar surges again as alopecia drug shows new promise in extension study pharminent April 20, 2026
Clinical Data Novo’s late-stage sickle cell win piles pressure on competitors pharminent April 20, 2026
Clinical Data Novo may have muscle advantage over Lilly in weight-loss race: preprint pharminent April 17, 2026
Clinical Data Lilly’s new obesity pill passes heart safety test in diabetes pharminent April 16, 2026
Clinical Data Lilly debuts more Foundayo data as FDA requests post-marketing trials pharminent April 16, 2026
Clinical Data Roche to start new Elevidys study following setback in Europe pharminent April 16, 2026
Clinical Data Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns pharminent April 16, 2026
Clinical Data Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study pharminent April 16, 2026
Clinical Data Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study pharminent April 16, 2026
